CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells

Experimental Hematology

Volumn 29, Issue 2, 2001, Pages 209-220

  Mahajan, Sudipta ^a,b   Gollob, Jared A ^a,b   Ritz, Jerome ^a,b   Frank, David A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adhesion molecules; Phosphorylation; Signal transduction; Transcription factors

Indexed keywords

CD2 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; STAT1 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ANTIBODIES; ANTIGENS, CD2; CELL LINE; CELL NUCLEUS; CYTOKINES; DNA-BINDING PROTEINS; GENES, FOS; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; INTERFERON-ALPHA; JURKAT CELLS; KILLER CELLS, NATURAL; KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0035146433     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00652-4     Document Type: Article

References (54)

1. An alternative pathway of T-cell activation; a functional role for the 50-kDa T11 sheep erythrocyte receptor protein
2. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein
3. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation
4. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59
5. Purified lymphocyte function-associated antigen-3 and T11 target structure are active in CD2-mediated T-cell stimulation
6. The CD3 ζ cytoplasmic domain mediates CD2-induced T cell activation
7. CD2-mediated signaling in T cells lacking the ζ-chain-specific immune receptor tyrosine-based activation (ITAM) motif
8. Tyrosine phosphorylation and association with phospholipase Cγ-1 of the GAP-associated 62-kD protein after CD2 stimulation of Jurkat cells
9. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway; Regulation by the CD45 tyrosine phosphatase
10. A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells
11. CD3ζ dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells
12. STATs and gene regulation
13. Transcriptional responses to polypeptide ligands; the Jak-Stat pathway
14. Signaling through hematopoietic cytokine receptors
15. Signal transduction pathways activated by ciliary neurotrophic factor and related cytokines
16. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
17. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans
18. Mutation of Jak3 in a patient with SCID; essential role of Jak3 in lymphoid development
19. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
20. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity of the JAK-STAT signaling pathway
21. c chain of the IL-2 receptor
22. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal; selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression
23. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia
24. Cell surface phenotype of a cloned line of human natural killer cells
25. IL-2 signaling involves the phosphorylation of novel Stat proteins
26. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus
27. Altered IL-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1
28. Stat1 implication in the immune response to superantigens in vivo
29. Regulation of interferon-γ-activated STAT1 by the ubiquitin-proteasome pathway
30. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation
31. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
32. + bifunctional cloned T cells toward proliferation or cytolytic function
33. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor
34. The role of interferon regulatory factors in the interferon system and cell growth control
35. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats
36. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases
37. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
38. Functional role of type I and type II interferons in antiviral defense
39. Immune response in mice that lack the interferon-γ receptor
40. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cδ
41. Tec and Jak2 cooperate to mediate cytokine-driven activation of c-fos transcription
42. Delayed tyrosine phosphorylation and nuclear expression of Stat1 following antigen receptor stimulation of lymphocytes
43. Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals
44. A family of cytokine-inducible inhibitors of signaling
45. A new protein containing an SH2 domain that inhibits JAK kinases
46. Structure and function of a new STAT-induced STAT inhibitor
47. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes; distinct STAT activation following surface Ig and CD40 receptor engagement
48. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12
49. CD2 regulates responsiveness of activated T cells to interleukin-12
50. Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells
51. A noncomitogenic CD2R monoclonal antibody induces apoptosis of activated T cells by a CD95/CD95-L-dependent pathway
52. CD2-induced apoptosis in activated human peripheral T cells; a Fas-independent pathway that requires early protein tyrosine phosphorylation
53. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis
54. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases